Learn How to Present a CMC Strategy That Gets Funded

Early-stage biotechs often lose funding because they fail to communicate effectively how their manufacturing strategy supports product and business success. This one-hour session fixes that problem.

In this webinar, Dr. Marta Kijanka,  founder of MK BioConsultancy, delivers practical frameworks and examples for presenting your CMC program to investors with clarity, credibility, and confidence — complete with example slides you can adapt immediately.

What You’ll Learn:

What investors actually evaluate in your CMC program – from technical readiness to supply chain robustness – and how to address their concerns proactively

CDMO selection, tech transfer, and analytical development presentations that demonstrate operational maturity and risk management

CMC milestone alignment with clinical and regulatory timelines to support accurate program valuation

Budget and timeline development based on facts, not aspirations — proving your team understands cost drivers and manufacturability risk

Communication mistakes that quietly undermine investor confidence — and how to turn them into proof points of competence 

This webinar previews the Biotech CMC Bootcamp at CDMO Live Europe 2026, where technical complexity meets business value that investment committees actually understand.